Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
DELPHI VENTURES VIII LP
- As of  04/27/24, 06:19:15 PM:   25 Insider Transactions.

Email this page to a friend.

Buy/Sell* 1 Yr Return** Filed Date Subject Symbol Pct Owned Details
B 2020-02-07 06:12:41.0 Calithera Biosciences CALA 4.6% view
S 2020-02-07 06:07:52.0 Senseonics Holdings SENS 4.9% view
B 2019-02-12 12:39:15.0 OncoMed Pharmaceuticals Inc OMED 5.4% view
S 2019-02-12 12:35:16.0 Senseonics Holdings SENS 5.7% view
S 2018-02-13 14:05:35.0 OncoMed Pharmaceuticals Inc OMED 5.4% view
S 2018-02-13 14:02:27.0 TANDEM DIABETES CARE INC TNDM 3.6% view
S 2018-02-13 13:57:30.0 Senseonics Holdings SENS 8.3% view
S 2017-06-06 19:20:54.0 Karyopharm Therapeutics Inc KPTI n/a view
S 2017-06-06 19:14:30.0 TANDEM DIABETES CARE INC TNDM 7.5% view
S 2017-06-06 19:06:13.0 Calithera Biosciences CALA n/a view
S 2017-04-04 14:10:20.0 Senseonics Holdings SENS 12.2% view
S 2017-02-14 14:40:02.0 Karyopharm Therapeutics Inc KPTI 5.5% view
S 2017-02-14 14:29:47.0 Calithera Biosciences CALA 11.2% view
S 2016-02-10 14:21:09.0 TriVascular Technologies TRIV 0.0% view
B 2016-02-08 06:03:22.0 Senseonics Holdings n/a 13.4% view
S 2015-03-17 15:48:15.0 TANDEM DIABETES CARE INC TNDM 12.4% view
S 2015-02-10 18:53:06.0 OncoMed Pharmaceuticals Inc OMED 6.7% view
B 2014-10-10 15:31:09.0 Calithera Biosciences CALA 13.6% view
B -38.34% 2014-04-23 19:00:08.0 TriVascular Technologies TRIV 18.5% view
B -20.55% 2014-02-06 18:50:49.0 OncoMed Pharmaceuticals Inc OMED 6.8% view
B -31.12% 2013-11-22 18:55:07.0 TANDEM DIABETES CARE INC TNDM 16.3% view
B 148.56% 2013-11-15 16:18:18.0 Karyopharm Therapeutics Inc KPTI 7.3% view
S 2013-02-06 20:22:41.0 NeuroMetrix NURO 2.7% view
S 2012-02-08 12:56:29.0 NeuroMetrix NURO 8.1% view
B -80.76% 2009-09-18 17:17:19.0 NeuroMetrix NURO 8.4% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.
** Since most institutions are long investors, only returns for long transactions are shown here.